Age-dependent administration and survival benefit of androgen deprivation therapy (ADT) vs. chemotherapy plus ADT (C plus ADT) in metastatic prostate cancer (mPC).-MedSci.cn

Age-dependent administration and survival benefit of androgen deprivation therapy (ADT) vs. chemotherapy plus ADT (C plus ADT) in metastatic prostate cancer (mPC).

Keating, M; Mukkamalla, SKR; Giscombe, L; Reddy, N; Desouza, A; Rathore, R

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):

科室
- - 订阅+
  - 更多科室
工具
服务